Summary: Evolving technologies and emergent guidelines are changing the way that HPV infection is screened and managed. Please join our distinguished faculty as they discuss 1) how to overcome barriers in your clinical practice that hinder your ability to screen and optimally counsel patients with or at risk for HPV infection; and 2) the role of HPV genotyping/cotesting when assessing the risk for cervical cancer in HPV-positive patients. 0.5 CME Credits
